Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Medpace Holdings (MEDP) Stock Price & Analysis

MEDP Stock Chart & Stats

MX$7,022.03MX$0.00(0.00%)
At close:
Mex$5KMex$7.5K28 Sep26 Apr22 Sep15 Apr30 Aug4 Apr25 Jun24 Apr
Day’s Range
MXN 7,022.03 - MXN 7,022.03
52-Week Range
MXN 5,880.00 - MXN 8,408.64
Previous Close
MXN 7,022.03
Volume
0
Average Volume (3M)
0
Market Cap
MXN 342.73B
Enterprise Value
MXN 17.18B
Total Cash (Recent Filing)
MXN 705.32M
Total Debt (Recent Filing)
MXN 146.04M
Price to Earnings (P/E)
35.5
Beta
-0.05
Next Earnings
Feb 15, 2027 (Est.)
EPS Estimate
90.41
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Profitable Growth

MEDP has substantially expanded revenue while maintaining strong operating and net margins, indicating that scale is translating into durable earnings power. Continued profitability provides resources to support investment, absorb operating variability, and reinforce the company’s position in outsourced clinical development.

Backlog Supports Revenue Visibility

A large backlog and substantial near-term conversion provide meaningful visibility into future service revenue. Rising awards over the last twelve months also indicate ongoing demand, helping support workforce planning, capacity utilization, and continued growth across multi-year clinical programs.

Conservative Balance Sheet

Low leverage gives MEDP financial flexibility as it executes its growth strategy and manages normal fluctuations in clinical-program timing. Limited balance-sheet strain can reduce financing pressure, preserve capacity for investment, and improve resilience if client activity or project starts become less predictable.

Bears Say

Clinical-program Cancellations

Cancellations can reduce backlog and interrupt revenue conversion when client programs fail, encounter safety signals, or are reprioritized. Management identifies cancellations as a major factor behind the historical slowdown in growth, so persistent levels could pressure visibility and utilization over the next several quarters.

Customer Concentration

A meaningful share of revenue comes from a relatively small group of customers, increasing the effect that a major program change, cancellation, or reprioritization could have on results. Concentration can make backlog conversion, growth rates, and resource utilization more variable than the overall market opportunity suggests.

Expansion-related Cost Pressure

The Cincinnati expansion creates a known cost headwind before its benefits are fully reflected in operations. Approximately $20 million of additional 2027 expense could temper margin expansion and earnings growth, particularly if demand or project starts do not scale quickly enough to absorb the added capacity.

Medpace Holdings News

MEDP FAQ

What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was Mex$5880.00 and its highest was Mex$8408.64 in the past 12 months.
What is Medpace Holdings’s market cap?
Medpace Holdings’s market cap is Mex$342.73B.
When is Medpace Holdings’s upcoming earnings report date?
Medpace Holdings’s next earnings report is estimated for Feb 15, 2027 (not yet confirmed), which is in 104 days.
How were Medpace Holdings’s earnings last quarter?
Medpace Holdings released its earnings results on Oct 21, 2026. The company reported Mex$90.518 earnings per share for the quarter, beating the consensus estimate of Mex$82.962 by Mex$7.556.
Is Medpace Holdings overvalued?
According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
Does Medpace Holdings pay dividends?
Medpace Holdings does not currently pay dividends.
What is Medpace Holdings’s EPS estimate?
Medpace Holdings’s EPS estimate is 90.41.
How many shares outstanding does Medpace Holdings have?
Medpace Holdings has 27,971,685 shares outstanding.
What happened to Medpace Holdings’s price movement after its last earnings report?
Medpace Holdings reported an EPS of Mex$90.518 in its last earnings report, beating expectations of Mex$82.962. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medpace Holdings?
Hedge funds hold Medpace Holdings shares: hedge funds decreased their holdings by 89.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology